ARTICLE | Company News
NICE recommends GSK's Strimvelis for ADA-SCID
January 5, 2018 10:07 PM UTC
The U.K.'s NICE issued a final appraisal determination recommending Strimvelis (2696273, GSK2696273) from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to treat adenosine deaminase (ADA) deficiency-severe c...
BCIQ Company Profiles
BCIQ Target Profiles